Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, 3-period crossover phase 2 study in patients with
documented hyperuricemia to evaluate the effect of tranilast on febuxostat pharmacokinetics
(PK) and pharmacodynamics (PD) and to evaluate the effect of febuxostat on tranilast PK and
PD as measured by reduction in serum uric acid levels.